[go: up one dir, main page]

Tissandier et al., 2001 - Google Patents

Testosterone, dehydroepiandrosterone, insulin-like growth factor 1, and insulin in sedentary and physically trained aged men

Tissandier et al., 2001

Document ID
2163376767575279451
Author
Tissandier O
Peres G
Fiet J
Piette F
Publication year
Publication venue
European journal of applied physiology

External Links

Snippet

The influence of physical activity on dehydroepiandrosterone sulfate (DHEAS), total and free testosterone (TT and FT, respectively), insulin-like growth factor I (IGF-1), follicle-stimulating hormone (FSH), luteinizing hormone (LH) and insulin concentrations in aging men was …
Continue reading at link.springer.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Tissandier et al. Testosterone, dehydroepiandrosterone, insulin-like growth factor 1, and insulin in sedentary and physically trained aged men
Salans et al. The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity
Johannsson et al. The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender.
Thompson et al. The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women
Loosen The TRH-induced TSH response in psychiatric patients: a possible neuroendocrine marker
Brodsky et al. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men--a clinical research center study
Wallace et al. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport
Manetta et al. Effect of training on the GH/IGF-I axis during exercise in middle-aged men: relationship to glucose homeostasis
Taaffe et al. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men
Nicklas et al. The menstrual cycle and exercise: performance, muscle glycogen, and substrate responses
Poehlman et al. The influence of endurance training on insulin-like growth factor-1 in older individuals
BOUGNERES et al. Effects of hypopituitarism and growth hormone replacement therapy on the production and utilization of glucose in childhood
O'Sullivan et al. Body composition and energy expenditure in acromegaly
Ho et al. Aging and growth hormone
FOSS et al. Peripheral glucose metabolism in acromegaly
AU738372B2 (en) Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3
Lange et al. Growth hormone enhances effects of endurance training on oxidative muscle metabolism in elderly women
Snow et al. Serum IGF-I is higher in gymnasts than runners and predicts bone and lean mass
Hornum et al. Exercise-induced changes in circulating growth factors with cyclic variation in plasma estradiol in women
MENEILLY et al. Impairment of noninsulin-mediated glucose disposal in the elderly
Simonson et al. Improved insulin sensitivity in patients with type I diabetes mellitus after CSII
Grandys et al. The effect of endurance training on muscle strength in young, healthy men in relation to hormonal status
Goeters et al. Repeated administration of recombinant human insulin-like growth factor-I in patients after gastric surgery. Effect on metabolic and hormonal patterns
Caldara et al. Effect of dopamine infusion on gastric and pancreatic secretion and on gastrin release in man.
Dahn et al. Systemic and splanchnic metabolic response to exogenous human growth hormone